DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Combination Chemotherapy Followed By Stem Cell Transplant in Treating Young Patients With Progressive or Relapsed Anaplastic Large Cell Lymphoma

Information source: National Cancer Institute (NCI)
Information obtained from ClinicalTrials.gov on October 19, 2009
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Lymphoma

Intervention: anti-thymocyte globulin (Biological); busulfan (Drug); carboplatin (Drug); carmustine (Drug); cyclosporine (Drug); cytarabine (Drug); dexamethasone (Drug); etoposide phosphate (Drug); idarubicin (Drug); ifosfamide (Drug); leucovorin calcium (Drug); lomustine (Drug); melphalan (Drug); methotrexate (Drug); mitoxantrone hydrochloride (Drug); prednisolone (Drug); thiotepa (Drug); vinblastine (Drug); vindesine (Drug); allogeneic hematopoietic stem cell transplantation (Procedure); autologous hematopoietic stem cell transplantation (Procedure); peripheral blood stem cell transplantation (Procedure); total-body irradiation (Radiation)

Phase: N/A

Status: Recruiting

Sponsored by: European Inter-Group Co-operation on Childhood Non-Hodgkin Lymphoma

Official(s) and/or principal investigator(s):
Alfred Reiter, MD, Study Chair, Affiliation: Kinderklinik
Denise Williams, MD, Affiliation: Cambridge University Hospitals NHS Foundation Trust

Summary

RATIONALE: Giving combination chemotherapy and total-body irradiation before a peripheral stem cell transplant that uses the patient's or a donor's stem cells, helps stop both the growth of cancer cells and the patient's immune system from rejecting the stem cells. When the stem cells are infused into the patient they may help the patient's bone marrow make stem cells, red blood cells, white blood cells, and platelets. Giving combination chemotherapy and total-body irradiation followed by a stem cell transplant may be an effective treatment for anaplastic large cell lymphoma.

PURPOSE: This clinical trial is studying how well combination chemotherapy followed by stem cell transplant works in treating young patients with progressive or relapsed anaplastic large cell lymphoma.

Clinical Details

Official title: Treatment Protocol for Relapsed Anaplastic Large Cell Lymphoma of Childhood and Adolescence

Study design: Treatment, Non-Randomized

Primary outcome: Event-free survival as measured by the Kaplan-Meier method

Secondary outcome:

Proportion of patients who are treated on protocol among all patients who meet the inclusion criteria

Overall survival

Acute and long term toxicity

Rate of acute and chronic graft-vs-host disease in patients with allogeneic stem cell transplantation

Treatment related mortality

Detailed description: OBJECTIVES:

Primary

- Improve the probability of event-free survival in children and adolescents with early

progression of anaplastic large cell lymphoma (ALCL) and/or relapse of ALCL with CD3-positive immunophenotype treated with reinduction combination chemotherapy followed by allogeneic or autologous stem cell transplantation.

- Determine whether a conditioning regimen comprising carmustine, etoposide phosphate,

cytarabine, and melphalan (BEAM) (without total body irradiation) for autologous stem cell transplantation is an effective treatment for patients with relapsed CD3-negative ALCL occurring after the intensive phase of treatment.

- Determine the impact of vinblastine in patients with late relapse of CD3-negative ALCL

who have not received vinblastine during frontline therapy.

Secondary

- Determine overall survival and treatment-related mortality in patients treated with

these regimens.

- Determine acute and long-term toxicity in patients treated with these regimens.

- Determine the rate of acute and chronic graft-vs-host disease in patients treated with

allogeneic stem cell transplantation.

OUTLINE: This is a multicenter, prospective, nonrandomized study. Patients are stratified according to time from initial diagnosis to progression/relapse, immunophenotype of lymphoma cells (CD3-positive + vs CD3-negative), stem cell donor availability (matched sibling donor vs 9/10 or 10/10 matched unrelated donor), and vinblastine during frontline therapy (yes vs no).

- Group 1 (early progression): Patients receive 1 course of ICM chemotherapy followed by

1 course of ICI chemotherapy.

- ICM chemotherapy: Patients receive methotrexate, cytarabine, and prednisolone

intrathecally (IT) on day 1, mitoxantrone hydrochloride IV over 5 hours on days 1 and 2, carboplatin IV continuously on days 2-5 and ifosfamide IV continuously on days 2-6.

- ICI chemotherapy: Patients receive methotrexate, cytarabine, and prednisolone

intrathecally on day 1, idarubicin IV over 4 hours on days 1 and 2, carboplatin IV continuously on days 2-5, and ifosfamide IV continuously on days 2-6.

Patients then proceed to allogeneic stem cell transplantation.

- Group 2 (relapsed disease and CD3-positive lymphoma cells): Patients are stratified

according to stem cell donor availability (yes vs no).

- Available donor: Patients receive 2 courses of CC chemotherapy and then proceed to

allogeneic stem cell transplantation.

- Unavailable donor : Patients receive 2 courses of CC chemotherapy comprising

dexamethasone orally or IV on days 1-5, vindesine IV on day 1, cytarabine IV over 3 hours on days 1 and 2, etoposide phosphate IV over 2 hours on days 3-5, and methotrexate, cytarabine, and prednisolone IT on day 5. Patients then receive 1 course of CVA chemotherapy comprising oral lomustine on day 1, vinblastine IV on days 1, 8, 15, and 22, and cytarabine IV over 1 hour on days 1-5. Patients undergo leukapheresis for collection of autologous peripheral blood stem cells after the first and/or second course of CC chemotherapy. Patients then proceed to autologous stem cell transplantation.

- Group 3 (relapsed disease, CD3-negative immunophenotype, and received vinblastine

during frontline therapy): Patients receive 2 courses of CC chemotherapy and 1 course of CVA chemotherapy as described above. Patients undergo leukapheresis for collection of autologous peripheral blood stem cells (PBSC) after the first and/or second course of CC chemotherapy. Patients then proceed to autologous stem cell transplantation.

- Group 4 (late relapse, CD3-negative immunophenotype, and did not receive vinblastine

during frontline therapy): Patients receive vinblastine IV once weekly for 24 months. Patients with disease progression during or relapsed disease after vinblastine therapy undergo treatment as in group 3.

- Autologous stem cell transplantation (SCT): Patients receive a conditioning regimen

comprising carmustine IV over 1 hour on day - 7, etoposide phosphate IV over 1 hour and

cytarabine IV over 30 minutes on days - 6 to -3, and melphalan IV over 15 minutes on day

- 2. Patients undergo autologous SCT on day 0.

- Allogeneic SCT: Beginning 4-6 weeks after the start of the last chemotherapy course,

patients receive 1 of the following conditioning regimens based on age:

- Patients > 2 years of age undergo total body irradiation on days -7 to -5 and

receive thiotepa IV over 1 hour on day - 4 and etoposide IV over 4 hours on day -3.

Patients undergo allogeneic SCT on day 0.

- Patients ≤ 2 years of age receive oral busulfan 4 times daily on days -8 to -5,

thiotepa IV over 1 hour twice on day - 4, and etoposide phosphate IV over 4 hours

on day - 3. Patients undergo allogeneic SCT on day 0.

Patients undergoing SCT from an unrelated donor also receive antithymocyte globulin IV over

4 hours on days - 3 to -1.

All patients receive graft-versus-host (GVHD) prophylaxis as described below.

- GVHD prophylaxis: GVHD prophylaxis is administered as per donor status.

- Matched sibling donor: Patients receive cyclosporine IV over 2 hours or orally on

day - 1 to 60 followed by a taper.

- 10/10 or 9/10 matched unrelated donor: Patients receive cyclosporine IV over 2

hours or orally on days - 1 to 100 followed by a taper, methotrexate IV on days 1,

3, and 6, and leucovorin calcium IV on days 2, 4, and 7.

- Mismatched donor: Patients do not receive GVHD prophylaxis, however, CD3-positive

lymphocytes are extracted from donor stem cells.

After completion of study treatment, patients are followed periodically for 10 years.

PROJECTED ACCRUAL: A total of 96 patients will be accrued for this study.

Eligibility

Minimum age: N/A. Maximum age: 21 Years. Gender(s): Both.

Criteria:

DISEASE CHARACTERISTICS:

- Histologically or cytologically confirmed anaplastic large cell lymphoma (ALCL)

- Progressive disease OR first relapse

- No second or subsequent relapse of ALCL

- Slides available for national central pathology review

- Availability of 1 of the following (for allogeneic stem cell transplantation only):

- HLA-identical matched sibling donor

- 10/10 HLA-matched nonsibling donor (related or unrelated)

- 9/10 HLA-matched nonsibling donor (1-antigen-mismatched related or unrelated

donor)

- < 9/10 HLA-mismatched donor (related or unrelated)

- Stem cells may be obtained from unmanipulated bone marrow or peripheral

blood stem cells after filgrastim (G-CSF) stimulation

PATIENT CHARACTERISTICS:

- Not pregnant or nursing

- Negative pregnancy test

- Fertile patients must use effective contraception

- Adequate hepatic, renal, and cardiac function

- No HIV infection or AIDS

- No severe immunodeficiency

- No other prior malignancy

- No pre-existing disease or condition prohibiting study treatment

PRIOR CONCURRENT THERAPY:

- At least 2 months since prior chemotherapy or radiotherapy

- No significant pretreatment for first relapse

- No prior organ transplantation

- No concurrent participation in another clinical trial

Locations and Contacts

St. Anna Children's Hospital, Vienna A-1090, Austria; Recruiting
Georg Mann, MD, Phone: 43-1-4017-1250

U.Z. Gasthuisberg, Leuven B-3000, Belgium; Recruiting
Anne Uyttebroeck, MD, Phone: 321-634-3841

Charles University Hospital, Prague 5 CZ-150 06, Czech Republic; Recruiting
E. Kabickova, Phone: 420-22-443-6424

University Hospital Brno, Brno CZ-662 63, Czech Republic; Recruiting
J. Sterba, Phone: 420-54-512-2614

Centre Leon Berard, Lyon 69373, France; Recruiting
Christophe Bergeron, Phone: 33-04-78-782642

Carl - Thiem - Klinkum Cottbus, Cottbus D-03048, Germany; Recruiting
D Mobius, MD, Phone: 49-355-462336

Charite University Hospital - Campus Virchow Klinikum, Berlin D-13353, Germany; Recruiting
Gunter Henze, Phone: 49-30-450-660-31

Children's Hospital, Cologne D-50924, Germany; Recruiting
Frank Berthold, MD, Phone: 49-221-478-4380, Email: frank.berthold@uk-koeln.de

Cnopf'sche Kinderklinik, Nuremberg 90419, Germany; Recruiting
A. Jobke, Phone: 49-911-3340-02

Comprehensive Cancer Center Ulm at Universitaetsklinikum Ulm, Ulm D-89075, Germany; Recruiting
Klaus M. Debatin, MD, Phone: 49-731-5002-7790, Email: klaus-michael.debatin@medizin.uni-ulm.de

Dr. Horst-Schmidt-Kliniken, Wiesbaden D-65199, Germany; Recruiting
Michael Albani, MD, Phone: 49-611-432-555 ext. 667, Email: michael.albani@hsk-wiesbaden.de

Dr. von Haunersches Kinderspital der Universitaet Muenchen, Munich D-80337, Germany; Recruiting
Arndt Borkhardt, Phone: 49-89-5160-4498

Evangelisches Krankenhauus Bielfeld, Biefeld 33617, Germany; Recruiting
N. Jorch, MD, Phone: 49-52-177-278-050

Gemeinschaftskrankenhaus, Herdecke 58313, Germany; Recruiting
Christoph Tautz, MD, Phone: 49-2330-62-3914, Email: ctautz@yahoo.de

Helios Kliniken Wuppertal University Hospital, Wuppertal D-42283, Germany; Recruiting
S. Wirth, MD, Phone: 49-202-896-2444 ext. 2491, Email: swirth@wuppertal.helios-kliniken.de

Helios Klinikum Berlin, Berlin 13125, Germany; Recruiting
A. Liebeskind, Phone: 49-30-9401-2359

Helios Klinikum Erfurt, Erfurt 99089, Germany; Recruiting
Axel Sauerbrey, MD, Phone: 49-361-781-3729, Email: asauerbrey@erfurt.helios-kliniken.de

Johannes Gutenberg University, Mainz D-55101, Germany; Recruiting
P. Gutjahr, MD, Phone: 49-6131-17-2112

Johanniter-Kinderklinik, St. Augustin 53757, Germany; Recruiting
Roswitha Dickerhoff, MD, Phone: 49-22-41-2491, Email: roswitha.dickerhoft@uni-bonn.de

Kinderklinik - Universitaetsklinikum Aachen, Aachen D-52074, Germany; Recruiting
R. Mertens, MD, PhD, Phone: 49-241-808-9902, Email: rmertens@ukaachen.de

Kinderklinik - Universitaetsklinikum Rostock, Rostock D-18057, Germany; Recruiting
G. Eggers, MD, Phone: 49-381-4940

Kinderklinik der Universitaet Bonn, Bonn D-53113, Germany; Recruiting
Udo Bode, MD, Phone: 49-228-2873-3215, Email: udo.bode@ukb.uni-bonn.de

Kinderklinik Kohlhof, Neunkirchen D-66539, Germany; Recruiting
Contact Person, Phone: Not Available

Kinderklinik, Giessen D-35385, Germany; Recruiting
Alfred Reiter, MD, Phone: 49-641-994-3420

Kinderklink Siegen Deutsches Rotes Kreuz, Siegen D-57072, Germany; Recruiting
Rainer Burghard, MD, Phone: 49-271-2345-0, Email: rainer.burghard@drk-kinderklinik.de

Klinik St. Hedwig-Kinderklinik, Regensburg 93049, Germany; Recruiting
Ove Peters, Phone: 49-941-369-5404

Klinik und Poliklinik fuer Kinder und Jugendmedizin - Universitaetsklinikum Muenster, Muenster D-48149, Germany; Recruiting
Heribert F. Juergens, MD, Phone: 49-251-834-7742, Email: jurgh@uni-muenster.de

Klinik und Poliklinik Fuer Kinder-und Jugendmedizin - Universitaetsklinikum Greifswald, Greifswald 17475, Germany; Recruiting
F. Beck, Phone: 49-3834-86-6324 ext. 6325

Kliniken der Stadt Koeln gGmbH - Kinderkrankenhaus Riehl, Cologne D-50735, Germany; Recruiting
Contact Person, Phone: 49-221-8907-5243

Klinikum Augsburg, Augsburg D-86156, Germany; Recruiting
P. Heidemann, MD, Phone: 49-821-400-3401, Email: lkk@klinikum-augsburg.de

Klinikum Bremen-Mitte, Bremen D-28205, Germany; Recruiting
Arnulf Pekrun, MD, PhD, Phone: 49-421-497-3656, Email: arnulf.pekrun@klinikum-bremen-mitte.de

Klinikum Chemnitz gGmbH, Chemnitz D-09116, Germany; Recruiting
K. Hofmann, MD, Phone: 49-371-333-241-24

Klinikum der J.W. Goethe Universitaet, Frankfurt D-60590, Germany; Recruiting
Thomas Klingebiel, MD, Phone: 49-69-6301-5094, Email: thomas.klingebiel@kgu.de

Klinikum Dortmund, Dortmund D-44137, Germany; Recruiting
Heidi Olscheswski, MD, Phone: 49-231-9532-1721

Klinikum Kassel, Kassel D-34125, Germany; Recruiting
F. K. Tegtmeyer, MD, Phone: 49-561-980-3365

Klinikum Kemperhof Koblenz, Koblenz D-56065, Germany; Recruiting
M. Rister, MD, Phone: 49-261-499-2602

Klinikum Krefeld GmbH, Krefeld D-47805, Germany; Recruiting
Schulte-Wissermann, Phone: 49-2151-32-2375

Klinikum Minden, Minden D-32423, Germany; Recruiting
W Tilmann, MD, Phone: 49-571-801-4601

Klinikum Oldenburg, Oldenburg 26133, Germany; Recruiting
Hermann Mueller, MD, Phone: 49-441-403-2013, Email: mueller.hermann@klinikum-oldenburg.de

Klinikum Schwerin, Schwerin D-19049, Germany; Recruiting
Clemens, Phone: 49-385-520-2710

Krankenanstalt Mutterhaus der Borromaerinnen, Trier D-54290, Germany; Recruiting
Wolfgang Rauh, MD, Phone: 49-651-947-2654

Krankenhaus Muenchen Schwabing, Munich 80804, Germany; Recruiting
Stefan Burdach, MD, PhD, Phone: 49-89-3068-2352

Medizinische Hochschule Hannover, Hannover D-30625, Germany; Recruiting
Karl Welte, MD, Phone: 49-511-532-6710, Email: welte.karl.h@mh-hannover.de

Olgahospital, Stuttgart D-70176, Germany; Recruiting
Stefan Bielack, MD, Phone: 49-711-99-24-61, Email: st.bielack@olgahospital.de

Saarbrucker Winterbergkliniken, Saarbrucken 66119, Germany; Recruiting
R Geib-Konig, MD, Phone: 49-681-963-2575

St. Annastift Krankenhaus, Ludwigshafen 67065, Germany; Recruiting
Barbara Selle, MD, Phone: 49-621-5702-4449

Staedtisches Klinik - Kinderklinik, Mannheim D-68167, Germany; Recruiting
M. Duerken, Phone: 49-621-383-2243

Staedtisches Klinikum - Howedestrase, Braunschweig 38118, Germany; Recruiting
Contact Person, Phone: 49-531-595-1222

Staedtisches Klinikum Karlsruhe gGmbH, Karlsruhe 76133, Germany; Recruiting
A. Leipold, Phone: 49-721-974-3311

Universitaets - Kinderklinik - Luebeck, Luebeck D-23538, Germany; Recruiting
Peter P. Bucsky, MD, Phone: 49-451-500-2956, Email: bucsky@paedia.ukl.mu-luebeck.de

Universitaets - Kinderklinik Wuerzburg, Wuerzburg D-97080, Germany; Recruiting
P. G. Schlegel, MD, Phone: 49-931-201-27-831, Email: schlegel@mail.uni-wuerzburg.de

Universitaets - Kinderklinik, Jena D-07745, Germany; Recruiting
Felix Zintl, MD, Phone: 49-3641-938-270

Universitaets - Kinderklinik, Erlangen D-91054, Germany; Recruiting
J.D. Beck, MD, Phone: 49-9131-853-3785, Email: joern.beck@kinder.imed.uni-erlangen.de

Universitaets - Kinderklinik, Leipzig D-04317, Germany; Recruiting
Dieter Koerholz, MD, Phone: 49-341-9726-246, Email: koerd@medizin.uni-leipzig.de

Universitaets - Kinderklinik, Marburg 35033, Germany; Recruiting
H. Christiansen, MD, Phone: 49-6421-286-2650

Universitaetskinderklinik - Universitaetsklinikum Freiburg, Freiburg D-79106, Germany; Recruiting
Charlotte Niemeyer, MD, Phone: 49-761-270-4506, Email: charlotte.niemeyer@uniklinik-freiburg.de

Universitaets-Kinderklinik Heidelberg, Heidelberg D-69120, Germany; Recruiting
Andreas E. Kulozik, MD, PhD, Phone: 49-6221-564-555, Email: andreas.kulozik@med.uni-heidelberg.de

Universitaetsklinikum des Saarlandes, Homburg 66421, Germany; Recruiting
Norbert Graf, Phone: 49-6841-162-4000

Universitaetsklinikum Duesseldorf, Duesseldorf D-40225, Germany; Recruiting
Contact Person, Phone: 49-211-311-7990

Universitaetsklinikum Essen, Essen D-45147, Germany; Recruiting
Bernhard Kremens, MD, Phone: 49-201-723-2453

Universitaetsklinikum Goettingen, Goettingen D-37075, Germany; Recruiting
Lothar Schweigerer, MD, Phone: 49-551-398-600

Universitaetsklinikum Tuebingen, Tuebingen D-72076, Germany; Recruiting
D. Niethammer, MD, Phone: 49-7071-298-4744

Universitatsklinikum Carl Gustav Carus, Dresden D-01307, Germany; Recruiting
M. Suttorp, MD, Phone: 49-351-458-0, Email: meinolf.suttorp@uniklinikum-dresden.de

Universitatsklinikum der MA, Magdeburg 39120, Germany; Recruiting
Uwe Mittler, MD, Phone: 49-391-67-17210

University Hospital Schleswig-Holstein - Kiel Campus, Kiel D-24105, Germany; Recruiting
Martin Schrappe, MD, PhD, Phone: 49-431-597-1620

University Medical Center Hamburg - Eppendorf, Hamburg D-20246, Germany; Recruiting
Gritta Janka-Schaub, Phone: 49-404-2803-2580

Vestische Kinderklinik, Datteln 45704, Germany; Recruiting
W. Andler, MD, Phone: 49-023-63-9750, Email: w.andler@kinderklinik-datteln.de

Our Lady's Hospital for Sick Children Crumlin, Dublin 12, Ireland; Recruiting
Fin Breatnach, MD, FRCPE, Phone: 353-1-409-6659, Email: fin.breatnach@olhsc.ie

Azienda Ospedaliera di Padova, Padova 35128, Italy; Recruiting
Angelo Rosolen, MD, Phone: 39-049-821-3579

Erasmus MC - Sophia Children's Hospital, Rotterdam 3015 GJ, Netherlands; Recruiting
Auke Beishuizen, MD, PhD, Phone: 31-10-463-6691

Akademia Medyczna im. Piastow Slaskich, Wroclaw 50-367, Poland; Recruiting
Grazyna Wrobel, Phone: 48-71-328-2040

Goeteborg University, Goeteborg S-141685, Sweden; Recruiting
Marky Ildiko, Phone: 46-31-343-4663

Kantonspital Aarau, Aarau CH-5001, Switzerland; Recruiting
R. Angst, Phone: 41-62-838-4906

Kinderspital Luzern, Lucerne 16 CH-6000, Switzerland; Recruiting
U. Caflisch, MD, Phone: 41-41-205-11-11

Ospedale "la Carita", Locarno, Locarno 6600, Switzerland; Recruiting
Luisa Nobile Buetti, MD, Phone: 41-91-756-7552

Ostschweizer Kinderspital, St. Gallen CH-9006, Switzerland; Recruiting
Jeanette Greiner, MD, Phone: 41-71-243-13-60, Email: jeanette.greiner@kispisg.ch

Universitaets-Kinderspital beider Basel, Basel CH-4005, Switzerland; Recruiting
Paul A. Imbach, MD, Phone: 41-61-685-6226

University Children's Hospital, Zurich CH-8032, Switzerland; Recruiting
Felix Niggli, MD, Phone: 41-44-266-7823

Addenbrooke's Hospital, Cambridge, England CB2 2QQ, United Kingdom; Recruiting
Amos Burke, MD, Phone: 44-1223-348-151

Birmingham Children's Hospital, Birmingham, England B4 6NH, United Kingdom; Recruiting
Martin W. English, MD, Phone: 44-121-333-8412, Email: martin.english@bch.nhs.uk

Children's Hospital - Sheffield, Sheffield, England S10 2TH, United Kingdom; Recruiting
Mary P. Gerrard, MBChB, FRCP, FRCPCH, Phone: 44-114-271-7366, Email: mary.gerrard@sch.nhs.uk

Great Ormond Street Hospital for Children, London, England WC1N 3JH, United Kingdom; Recruiting
Gill Levitt, MD, Phone: 44-20-7405-9200 ext. 0073

Institute of Child Health at University of Bristol, Bristol, England BS2 8AE, United Kingdom; Recruiting
Pamela Kearns, MD, Phone: 44-117-342-0205

Leeds Cancer Centre at St. James's University Hospital, Leeds, England LS9 7TF, United Kingdom; Recruiting
Adam Glaser, MD, Phone: 44-113-206-4984, Email: adam.glaser@leedsth.nhs.uk

Leicester Royal Infirmary, Leicester, England LE1 5WW, United Kingdom; Recruiting
Mabrouk Madi, MD, Phone: 44-116-258-5959

Middlesex Hospital, London, England W1T 3AA, United Kingdom; Recruiting
Ananth Shankar, MD, Phone: 44-20-7380-9300 ext. 9950

Oxford Radcliffe Hospital, Oxford, England 0X3 9DU, United Kingdom; Recruiting
Kate Wheeler, MD, Phone: 44-186-522-1066

Queen's Medical Centre, Nottingham, England NG7 2UH, United Kingdom; Recruiting
Martin Hewitt, MD, BSc, FRCP, FRCPCH, Phone: 44-115-924-9924 ext. 63394, Email: martin.hewitt@nuh.nhs.uk

Royal Liverpool Children's Hospital, Alder Hey, Liverpool, England L12 2AP, United Kingdom; Recruiting
Heather P. McDowell, MD, Phone: 44-151-293-3679

Royal Manchester Children's Hospital, Manchester, England M27 4HA, United Kingdom; Recruiting
Robert F. Wynn, MD, Phone: 44-161-922-2172, Email: robert.wynn@cmmc.nhs.uk

Royal Marsden - Surrey, Sutton, England SM2 5PT, United Kingdom; Recruiting
Mary Taj, MD, Phone: 44-20-8642-6011 ext. 3089

Sir James Spence Institute of Child Health at Royal Victoria Infirmary, Newcastle-Upon-Tyne, England NE1 4LP, United Kingdom; Recruiting
Juliet Hale, MD, Phone: 44-191-282-4101, Email: j.p.hale@ncl.ac.uk

Southampton General Hospital, Southampton, England SO16 6YD, United Kingdom; Recruiting
Janice A. Kohler, MD, FRCP, Phone: 44-23-8079-6942

Royal Belfast Hospital for Sick Children, Belfast, Northern Ireland BT12 6BE, United Kingdom; Recruiting
Anthony McCarthy, MD, Phone: 44-289-063-3631, Email: anthonymcarthy@royalhospital.n.i.nhs.uk

Royal Aberdeen Children's Hospital, Aberdeen, Scotland AB25 2ZG, United Kingdom; Recruiting
Veronica Neefjes, Phone: 44-1224-550-217

Royal Hospital for Sick Children, Glasgow, Scotland G3 8SJ, United Kingdom; Recruiting
Milind D. Ronghe, MD, Phone: 44-141-201-9309

Royal Hospital for Sick Children, Edinburgh, Scotland EH9 1LF, United Kingdom; Recruiting
W. Hamish Wallace, MD, Phone: 44-131-536-0426

Childrens Hospital for Wales, Cardiff, Wales CF14 4XW, United Kingdom; Recruiting
Heidi Traunecker, MD, PhD, Phone: 44-29-2074-2285, Email: heidi.traunecker@cardiffandvale.wales.nhs.uk

Additional Information

Clinical trial summary from the National Cancer Institute's PDQ® database

Starting date: April 2004
Last updated: July 2, 2009

Page last updated: October 19, 2009

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012